SPRINGFIELD — U.S. Senate Democratic Whip Dick Durbin (D-IL) today released the following statement on the formation of the Biden-Harris Transition COVID-19 Advisory Board, a team of leading public health and medical experts who will advise President-elect Joe Biden and Vice President-elect Kamala Harris on their response to the coronavirus pandemic:

“President-elect Biden’s and Vice President-elect Harris’ COVID-19 task force is comprised of respected professionals, truth tellers, and real leaders. I have worked with many over the years, especially co-chair Dr. David Kessler, as a committed leader on public health issues, and Dr. Julie Morita, who helped lead the Chicago Department of Public Health for nearly two decades. America can turn the corner on this pandemic if we pull together and listen to our trusted scientific experts.”

Article continues after sponsor message

Get The Latest News!

Don't miss our top stories and need-to-know news everyday in your inbox.

The Biden-Harris Transition COVID-19 Advisory Board will be led by co-chairs Dr. David Kessler, Dr. Vivek Murthy, and Dr. Marcella Nunez-Smith. Dr. Julie Morita, who helped lead the Chicago Department of Public Health for nearly two decades as medical director, chief medical officer, and commissioner, is a member of the advisory board.

Prefer RiverBender on Google
Copyright 2026 Riverbender.com. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

 

More like this:

Illinois Department Of Public Health Urges Public To Get Vaccinated Ahead Of Respiratory Virus Season
Sep 14, 2026
Two New Conditions Now Eligible For Treatment With Medical Cannabis
Aug 25, 2026
Illinois Releases 2026 Annual Cannabis Report Highlighting Continued Growth, Expanded Access And Regulatory Oversight
5 days ago
New Family Medicine Physician and Orthopedic Sports Medicine Provider To Practice In O'Fallon, IL.
Sep 17, 2026
Durbin Praises Dr. Fauci On The Senate Floor For His Significant Contributions To Public Health And Life-saving Research
Aug 4, 2026